Market cap
$20,209 Mln
Revenue (TTM)
$2,459 Mln
P/E Ratio
--
P/B Ratio
7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 7.80 | 28.20 | 50.46 | 46.15 | 50.47 |
| EBIT | -12.23 | 10.88 | 33.33 | 10.34 | -0.92 |
| Net Profit | -0.78 | -156.33 | 10.32 | 10.20 | -2.10 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -75.10 | -176.87 | -49.30 | -49.30 | -126.68 |
| Net Margin
| -- | -290.32 | -- | -- | -- |
| Return on equity
| -28.30 | -35.78 | -24.93 | -22.26 | -37.71 |
| Return on Capital
| -23.55 | -30.36 | -19.74 | -18.10 | -32.82 |
| Return on Assets
| -18.78 | -24.11 | -15.19 | -14.47 | -26.67 |
| Debt to Equity (x)
| -- | -- | 0.26 | 0.26 | 0.20 |
Profitability
ROCE
-19.74
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
-19.74
|
-18.10
|
-32.82
|
-24.86
|
-56.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-24.93
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
-24.93
|
-22.26
|
-37.71
|
-27.95
|
-66.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-15.19
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
-15.19
|
-14.47
|
-26.67
|
-19.84
|
-44.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-49.30
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
-49.30
|
-49.30
|
-126.68
|
-122.39
|
-536.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-35.86
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
-35.86
|
-35.86
|
-141.52
|
-118.55
|
-462.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
--
|
0.74
|
0.20
|
2.81
|
-0.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
--
|
32.41
|
-24.59
|
13.15
|
-72.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
--
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
--
|
56.00
|
-41.78
|
11.69
|
-68.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.26
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
0.26
|
0.26
|
0.20
|
0.11
|
0.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.20
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
0.20
|
0.20
|
0.09
|
0.08
|
0.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.32
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
2.32
|
2.32
|
4.63
|
4.76
|
4.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
2.09
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
2.09
|
2.09
|
4.35
|
4.61
|
4.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
--
|
-32.44
|
-34.18
|
-91.37
|
-4,904.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
16.10
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
16.10
|
16.10
|
12.23
|
42.52
|
25.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.42
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
0.42
|
0.40
|
0.19
|
0.17
|
0.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
58.81
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
58.81
|
42.27
|
86.85
|
90.02
|
90.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
400.05
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
400.05
|
335.75
|
49.75
|
37.32
|
15.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
302.94
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
302.94
|
293.17
|
43.86
|
44.98
|
47.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
155.92
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
155.92
|
84.84
|
92.74
|
82.37
|
58.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
EV/EBITDA
2.00
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BeiGene (BGNE)
|
2.00
|
2.00
|
2.11
|
4.25
|
2.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|